Trust Point Inc’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$239K Sell
1,755
-832
-32% -$102K 0.02% 404
2026
Q1
$305K Sell
2,587
-93
-3% -$13K 0.03% 384
2025
Q4
$439K Buy
2,680
+54
+2% +$8.46K 0.03% 262
2025
Q3
$351K Buy
2,626
+253
+11% +$30.7K 0.03% 322
2025
Q2
$295K Sell
2,373
-1,383
-37% -$176K 0.03% 294
2025
Q1
$478K Sell
3,756
-2,030
-35% -$312K 0.04% 224
2024
Q4
$833K Sell
5,786
-2,107
-27% -$302K 0.06% 190
2024
Q3
$1.17M Buy
7,893
+359
+5% +$51.5K 0.09% 136
2024
Q2
$950K Buy
7,534
+1,558
+26% +$244K 0.08% 162
2024
Q1
$1.1M Buy
5,976
+1,717
+40% +$327K 0.09% 138
2023
Q4
$766K Buy
+4,259
New +$663K 0.06% 177

Other funds holding RGEN

Trust Point Inc's RGEN Position: Q2 2026 in Review

Trust Point Inc reduced its Repligen (RGEN) stake by 32% in Q2 2026, selling an estimated $102K and leaving 1,755 shares worth $239K. The position accounts for 0.02% of the portfolio, ranked #404.

Trust Point Inc first reported a position in RGEN in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.17M in Q3 2024. 59 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Trust Point Inc held 1,755 shares of Repligen worth $239K as of Q2 2026.
  • Trust Point Inc sold 832 Repligen shares in Q2 2026, an estimated $102K.
  • Repligen made up 0.02% of Trust Point Inc's portfolio in Q2 2026, its #404 holding.
  • Trust Point Inc first reported a position in Repligen in Q4 2023 and has held it in 11 quarters since.
  • Trust Point Inc's Repligen position peaked at $1.17M in Q3 2024.
  • 59 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Trust Point Inc's 13F filing for Q2 2026, filed 8 Jul 2026.